Feature Channels:

Neuro

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Alzheimer's, Alzheimer's Disease, Prevention, Vaccine, Clinical Trial, Keck School Of Medicine Of Usc, USC, Lon Schneider, Generation Study, Apoe 4, Amyloid Beta, Clinical Drug Trials, Clinical Drug Development

New Study Investigates Vaccine and Oral Medication to Stop Alzheimer’s Years Before It Begins

amyloidforblog.jpg

The Keck School of Medicine of USC launches a new study investigating a vaccine and oral medication to stop Alzheimer’s years before it begins

Medicine

Channels:

Women’s Quality of Life Impacted More Than Men With Myasthenia Gravis

Today, at the 2017 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, Dr. Ikjae Lee, Assistant Professor of Neurology at the University of Alabama at Birmingham, was honored as the Best Abstract Award Winner for his research, Gender and Quality of Life In Myasthenia Gravis Patients From The Myasthenia Gravis Foundation of America Registry.

Medicine

Channels:

Research Highlights Therapeutic Effect of Dialysis on Nerve Structure and Function

Today, at the 2017 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, Adeniyi Borire, MBBS, was honored with the 2017 Golseth Young Investigator Award for his abstract, Effects of Haemodialysis on Intraneural Blood Flow in End-Stage Kidney Disease.

Medicine

Channels:

10 Research Studies Improving Neuromuscular Patient Care from the AANEM Annual Meeting

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) honored 10 neuromuscular (NM) and electrodiagnostic (EDX) abstracts with its President’s Research Initiative Award at the 2017 AANEM Annual Meeting in Phoenix.

Medicine

Channels:

multiple sclerosis, MS, Multiple Sclerosis Research, Fatigue, fatigue and MS, MS fatigue, Neurology, Cognitive Behavioral Therapy

University of Michigan Researchers Awarded Nearly $3.5 Million to Fight Fatigue in Multiple Sclerosis

twittercombopic.JPG

A new clinical trial will explore three interventions in improving one of the most disabling symptoms for people with multiple sclerosis: fatigue. The Patient-Centered Outcomes Research Institute has approved a $3,476,448 funding award over four years to Michigan Medicine’s Tiffany Braley, M.D., M.S. and Anna Kratz, Ph.D.

Medicine

Channels:

Vitamin D Levels in Blood May Help Predict Risk of MS

Examining vitamin D levels in the blood may help predict whether a person is at risk of developing multiple sclerosis (MS), according to a large new study published in the September 13, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Medicine

Channels:

Lupus, Rheumatology, E, st, Inflammation, Lupus Nephritis

Regular Exercise, Stress Can Both Make a Big Difference in Lupus, Study Finds

Waking up in the morning with the joint pain, swelling and stiffness that accompanies lupus doesn’t exactly inspire a workout. But research in mice and a related pilot study in humans are showing how regular activity and stress reduction could lead to better health in the long run.

Medicine

Channels:

Glioblastoma, hospital volume, cancer outcomes, Patient Care

Treatment Nonexistent for Some Glioblastoma Patients

KoshyMatt.jpg

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

Medicine

Channels:

Neurorehabilitation, spine injury, Brain-computer, NSF, Research

UCI Heads $8 Million NSF-Funded Project to Develop Brain-Computer Interface

The National Science Foundation has awarded $8 million to a consortium led by the University of California, Irvine to develop a brain-computer interface that can restore walking ability and sensation in individuals with spinal cord injury. This initiative represents the largest NSF award received by faculty researchers in the UCI engineering and medicine schools.

Medicine

Channels:

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

/PRNewswire-USNewswire/ -- Nearly 200 academic and industry researchers came together to share updates on preclinical and clinical-stage Alzheimer's disease research at the 18th Annual Conference on Alzheimer's Drug Discovery. The two-day conference, organized by the Alzheimer's Drug Discovery Foundation (ADDF), is the first and only to focus solely on non-amyloid drug programs in development.







Chat now!